UY28972A1 - VACCINES AGAINST FASCIOLA HEPATICA USING CODIFYING RECOMBINATING DNA MOLECULES FOR LEUCIN AMINOPEPTIDASES. - Google Patents

VACCINES AGAINST FASCIOLA HEPATICA USING CODIFYING RECOMBINATING DNA MOLECULES FOR LEUCIN AMINOPEPTIDASES.

Info

Publication number
UY28972A1
UY28972A1 UY28972A UY28972A UY28972A1 UY 28972 A1 UY28972 A1 UY 28972A1 UY 28972 A UY28972 A UY 28972A UY 28972 A UY28972 A UY 28972A UY 28972 A1 UY28972 A1 UY 28972A1
Authority
UY
Uruguay
Prior art keywords
fasciola hepatica
codifying
leucin
aminopeptidases
dna molecules
Prior art date
Application number
UY28972A
Other languages
Spanish (es)
Inventor
Carlos Carmona
Daniel Acosta
Jose Tort
Leda Roche
Martin Cancela
Original Assignee
Carlos Carmona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlos Carmona filed Critical Carlos Carmona
Priority to UY28972A priority Critical patent/UY28972A1/en
Publication of UY28972A1 publication Critical patent/UY28972A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Fasciola hepatica es un helminto parásito que afecta fundamentalmente al ganado ovino y bovino. El tema de la invención es un polipéptido producido en un microorganismo genéticamente modificado que contienen la secuencia completa de amino ácidos correspondiente a la leucin aminopeptidasa de Fasciola hepatica, una enzima proteolítica localizada en el tubo digestivo del gusano; y su aplicación a la inmunización contra la infección producida por el parásito en rumiantes.Fasciola hepatica is a parasitic helminth that primarily affects sheep and cattle. The subject of the invention is a polypeptide produced in a genetically modified microorganism containing the complete amino acid sequence corresponding to the leucine aminopeptidase of Fasciola hepatica, a proteolytic enzyme located in the worm's digestive tract; and its application to immunization against infection caused by the parasite in ruminants.

UY28972A 2005-06-20 2005-06-20 VACCINES AGAINST FASCIOLA HEPATICA USING CODIFYING RECOMBINATING DNA MOLECULES FOR LEUCIN AMINOPEPTIDASES. UY28972A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY28972A UY28972A1 (en) 2005-06-20 2005-06-20 VACCINES AGAINST FASCIOLA HEPATICA USING CODIFYING RECOMBINATING DNA MOLECULES FOR LEUCIN AMINOPEPTIDASES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY28972A UY28972A1 (en) 2005-06-20 2005-06-20 VACCINES AGAINST FASCIOLA HEPATICA USING CODIFYING RECOMBINATING DNA MOLECULES FOR LEUCIN AMINOPEPTIDASES.

Publications (1)

Publication Number Publication Date
UY28972A1 true UY28972A1 (en) 2006-04-28

Family

ID=38813070

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28972A UY28972A1 (en) 2005-06-20 2005-06-20 VACCINES AGAINST FASCIOLA HEPATICA USING CODIFYING RECOMBINATING DNA MOLECULES FOR LEUCIN AMINOPEPTIDASES.

Country Status (1)

Country Link
UY (1) UY28972A1 (en)

Similar Documents

Publication Publication Date Title
Gupta et al. Biotechnological applications and prospective market of microbial keratinases
AR049014A1 (en) MIMETICBODIES OF GLP-1 HUMANS, COMPOSITIONS AND USES
PE20140220A1 (en) ANTIGEN BINDING PROTEINS AGAINST PROPROTEIN CONVERSTASE SUBTILISIN / KEXIN TYPE 9 (PCSK9)
EA201270517A1 (en) МИКОБАКТЕРИАЛЬНЫЕ ВАКЦИНЫ
ES2532985T3 (en) Shiga toxoid chimeric proteins
NZ597769A (en) Proteins and nucleic acids from meningitis/sepsis-associated Escherichia Coli
AR069020A1 (en) COMPOSITION FOR HAIR CARE
CR20110206A (en) METHOD OF USE OF A SEPA DE BACILLUS SUBTILIS TO IMPROVE ANIMAL HEALTH
BR0313492A (en) Human antibody formulation to treat tnf-alpha associated disorders
ATE376434T1 (en) INJECTION DEVICE FOR MRNA APPLICATION
AR066199A1 (en) METHOD TO REDUCE THE CONCENTRATION OF THE BETA AMYLOID PEPTIDE
NO20060994L (en) Biological non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food
EP3552622A3 (en) Priming of an immune response
NZ598834A (en) Prevention, treatment and diagnosis of P. gingivalis infection
WO2009034315A3 (en) Vaccine
Raina et al. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins
BRPI0314666B8 (en) nutritional or therapeutic composition usable for the treatment of mammals to increase immune activity
EA201070292A1 (en) METHOD FOR ACTIVATING REGULATORY T-CELLS
ES2531372T3 (en) Processing enzymes fused to basic protein markers
ATE541581T1 (en) DRUG FOR CANCER THERAPY
EA201070177A1 (en) SEXUAL PEPTIDES SUSTAINABLE TO PROTEOLYTIC DIVISION AND APPLICATION OF THE SPECIFIED PEPTIDES FOR BIOLOGICAL INSPECTION
DOP2006000116A (en) IMPROVED REGULATED EXPRESSION SYSTEM AND ITS USES.
UY28972A1 (en) VACCINES AGAINST FASCIOLA HEPATICA USING CODIFYING RECOMBINATING DNA MOLECULES FOR LEUCIN AMINOPEPTIDASES.
UY26763A1 (en) IMMUNIZATION OF DAIRY CATTLE WITH CHEMICAL GAPC PROTEIN AGAINST STREPTOCOCCAL INFECTION.
Abdel Aziz et al. Immunogenicity and protective capacity of Schistosoma haematobium recombinant cathepsin L against infection of hamsters with S. haematobium

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20161207